Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

Cigna partners with Weill Cornell to form ACO

Cigna and the Weill Cornell Physician Organization, an 850-member group practice in New York City, are partnering to create a collaborative accountable care organization (ACO) initiative, which will adopt a healthcare delivery model similar to the ones demonstrated by accountable care organizations and patient-centered medical homes.

Health Affairs: More light shed on healthcare reform's day in Supreme Court

The Supreme Court is filling its entire court calendar the week of March 26 with arguments relating to the impending review of the constitutionality of the Patient Protection and Affordable Care Act (PPACA); totaling five and a half hours over three days with a decision expected in late June.

HHS relaxes state requirements in healthcare reform law

The Department of Health and Human Services released a bulletin Dec. 15, outlining proposed policies that will give states more flexibility and freedom to implement the Patient Protection and Affordable Care Act (PPACA).

Displaying 3505 - 3507 of 3507

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.